Personalized treatment of hepatitis B

Personalized treatment of hepatitis B

There are seven approved drugs for treatment of hepatitis B. Professional guidelines provide a framework for managing patients but these guidelines should be interpreted in the context of the individual patient's clinical and social circumstances. Personalized management of hepatitis B can be a...

Full description

Bibliographic Details
Main Author: Anna S. Lok
Format: Article
Language:English
Published: Korean Association for the Study of the Liver 2015-03-01
Series:Clinical and Molecular Hepatology
Subjects:
Hepatitis B virus
Chronic hepatitis B
Management
Personalized medicine
Online Access:http://e-cmh.org/upload/pdf/cmh-21-1.pdf
id doaj-a9c5f25f0346423fb521ffa5f8c50846
record_format Article
spelling doaj-a9c5f25f0346423fb521ffa5f8c508462020-11-24T22:50:13ZengKorean Association for the Study of the LiverClinical and Molecular Hepatology2287-27282287-285X2015-03-012111610.3350/cmh.2015.21.1.11122Personalized treatment of hepatitis BAnna S. Lok0Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI, USA.There are seven approved drugs for treatment of hepatitis B. Professional guidelines provide a framework for managing patients but these guidelines should be interpreted in the context of the individual patient's clinical and social circumstances. Personalized management of hepatitis B can be applied based on prediction of the individual patient's risk of cirrhosis and hepatocellular carcinoma to guide the frequency and intensity of monitoring and urgency of treatment. It can also be applied to decisions regarding when to start treatment, which drug to use, and when to stop based on the individual patient's disease characteristics, preference, comorbidities and other mitigating circumstances.http://e-cmh.org/upload/pdf/cmh-21-1.pdfHepatitis B virusChronic hepatitis BManagementPersonalized medicine
collection DOAJ
language English
format Article
sources DOAJ
author Anna S. Lok
spellingShingle Anna S. Lok
Personalized treatment of hepatitis B
Clinical and Molecular Hepatology
Hepatitis B virus
Chronic hepatitis B
Management
Personalized medicine
author_facet Anna S. Lok
author_sort Anna S. Lok
title Personalized treatment of hepatitis B
title_short Personalized treatment of hepatitis B
title_full Personalized treatment of hepatitis B
title_fullStr Personalized treatment of hepatitis B
title_full_unstemmed Personalized treatment of hepatitis B
title_sort personalized treatment of hepatitis b
publisher Korean Association for the Study of the Liver
series Clinical and Molecular Hepatology
issn 2287-2728
2287-285X
publishDate 2015-03-01
description There are seven approved drugs for treatment of hepatitis B. Professional guidelines provide a framework for managing patients but these guidelines should be interpreted in the context of the individual patient's clinical and social circumstances. Personalized management of hepatitis B can be applied based on prediction of the individual patient's risk of cirrhosis and hepatocellular carcinoma to guide the frequency and intensity of monitoring and urgency of treatment. It can also be applied to decisions regarding when to start treatment, which drug to use, and when to stop based on the individual patient's disease characteristics, preference, comorbidities and other mitigating circumstances.
topic Hepatitis B virus
Chronic hepatitis B
Management
Personalized medicine
url http://e-cmh.org/upload/pdf/cmh-21-1.pdf
work_keys_str_mv AT annaslok personalizedtreatmentofhepatitisb
_version_ 1725673445864243200

Similar Items